The Prostaglandin E2 kit is designed for the rapid detection of PGE2 in cell supernatant and whole cells.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Protein Quantification |
Dynamic Range | 8 - 1,000 pg/mL |
Limit of Detection | 10 pg/mL |
Sample Volume | 10 µL |
The Prostaglandin E2 kit is designed for the rapid detection of PGE2 in cell supernatant and whole cells.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Prostaglandin E2 (PGE2) is produced in multiple cell types from PGH2, a primary product of the arachidonic acid metabolism, via the prostaglandin synthase. PGE2 displays several biological functions, such as vasodilatation and smooth muscle relaxation, and is involved in pro- and anti-inflammation pathways. PGE2 production is a commonly used method for the detection of COX-1 and COX-2 modulation. The PGE2 kit is a highly sensitive method for quantifying PGE2, either in cell supernatant or directly in whole cells.
Application |
Protein Quantification
|
---|---|
Brand |
HTRF
|
Detection Modality |
HTRF
|
Dynamic Range |
8 - 1,000 pg/mL
|
Limit of Detection |
10 pg/mL
|
Product Group |
Kit
|
Sample Volume |
10 µL
|
Shipping Conditions |
Shipped Ambient
|
Target Class |
Biomarkers
|
Technology |
TR-FRET
|
Therapeutic Area |
Cardiovascular
Neuroscience
Oncology & Inflammation
|
Unit Size |
500 Assay Points
|
The PGE2 assay is based on the competition principle, where native PG2 produced by cells and d2-labelled PGE2 compete for binding to a monoclonal anti-PGE2 antibody labelled with Europium Cryptate. The assay can be run with several types of samples, such as cell supernatants or purified enzymes.
The PGE2 assay features a streamlined protocol with only 1 incubation step after sample and PGE2 detection reagents dispensing. This protocol requires a single 5-hour incubation period at RT.
The PGE2 assay has a high level of flexibility. It can be performed using cell supernatants or directly on stimulated cells. The incubation time and temperature following addition of the detection reagents have little effect on the assay results, providing further assay flexibility.
Detection limit | 10 pg/mL |
---|---|
Dynamic range | 8 to 1000 pg/mL |
EC50 | 250 pg/mL |
S/B | 31 |
Z' | 0.9 for 20 µl assay volumes |
One benefit of the HTRF PGE2 assay is its ability to quantify PGE2 in the presence of cells without sacrificing assay performance. The results comparing direct cell-based versus supernatant transfer did not differ significantly. Monocytes were stimulated to produce PGE2 in the presence or absence of indomethacin, a known inhibitor of PGE2 production. The IC50 of indomethacin determined using HTRF technology (1.0 ± 0.4 nM) was in agreement with previously published data.
Are you looking for resources, click on the resource type to explore further.
Dive deeper into fibrosis research
In fibrotic disorders, the normal regulation of the extracellular matrix (ECM) is compromised...
Fibrotic disorders are complex diseases believed to stem from uncontrolled and excessive wound healing processes. The exact causes...
Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...
This guide provides you an overview of HTRF applications in several therapeutic areas.
We are here to answer your questions.